ASSOCIATION OF HSCRP WITH HIGH-RISK OF CARDIOVASCULAR DISEASE IN PATIENTS WITH SCHIZOPHRENIA

被引：0
|
作者：
Yao, Jeffrey K. [1 ,2 ]
Reddy, R. [1 ,2 ]
Dougherty, G. [1 ,2 ]
Magan, S. [1 ]
Gurklis, J. [1 ,2 ]
Sonel, A. [1 ]
Sonel, E. [1 ]
Kisslinger, B. [1 ]
Keshavan, Matcheri [2 ,3 ,4 ]
Chengappa, K. [2 ]
机构：
[1] VA Pittsburgh Healthcare Syst, Med Res Serv, Pittsburgh, PA USA
[2] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA
[3] Beth Israel Deaconess Med Ctr, Dept Psychiat, Boston, MA 02215 USA
[4] Harvard Univ, Boston, MA 02115 USA
来源：
SCHIZOPHRENIA BULLETIN | 2011年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：120 / 120
页数：1
相关论文
共 50 条
  • [31] Is the High-Risk Strategy to Prevent Cardiovascular Disease Equitable?
    Kildemoes, Helle Wallach
    Diderichsen, Finn
    Lange, Theis
    Andersen, Morten
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S25 - S26
  • [32] Screening for High-Risk Cardiovascular Disease A Challenge for the Guidelines
    Smith, Sidney C., Jr.
    ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (01) : 40 - 42
  • [33] Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs
    Abu-Farha, Mohamed
    Behbehani, Kazem
    Elkum, Naser
    CARDIOVASCULAR DIABETOLOGY, 2014, 13
  • [34] Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs
    Mohamed Abu-Farha
    Kazem Behbehani
    Naser Elkum
    Cardiovascular Diabetology, 13
  • [35] ARBs for cardiovascular and renal protection in high-risk patients
    Aalbers, J.
    CARDIOVASCULAR JOURNAL OF AFRICA, 2011, 22 (04) : 224 - 224
  • [36] CARDIOVASCULAR MORBIDITY IN HIGH-RISK PATIENTS DURING ECT
    RICE, EH
    SOMBROTTO, LB
    MARKOWITZ, JC
    LEON, AC
    AMERICAN JOURNAL OF PSYCHIATRY, 1994, 151 (11): : 1637 - 1641
  • [37] Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
    Ridker, P. M.
    Revkin, J.
    Amarenco, P.
    Brunell, R.
    Curto, M.
    Civeira, F.
    Flather, M.
    Glynn, R. J.
    Gregoire, J.
    Jukema, J. W.
    Karpov, Y.
    Kastelein, J. J. P.
    Koenig, W.
    Lorenzatti, A.
    Manga, P.
    Masiukiewicz, U.
    Miller, M.
    Mosterd, A.
    Murin, J.
    Nicolau, J. C.
    Nissen, S.
    Ponikowski, P.
    Santos, R. D.
    Schwartz, P. F.
    Soran, H.
    White, H.
    Wright, R. S.
    Vrablik, M.
    Yunis, C.
    Shear, C. L.
    Tardif, J. -C.
    Conde, Diego
    Colquhoun, David
    Missault, Luc
    Gregoire, Jean
    Gao, Runlin
    Urina, Miguel
    Solar, Miroslav
    Jensen, Henrik Kjaerulf
    Grobbee, Diederick
    Savolainen, Markku
    Schiele, Francois
    Montalescot, Gilles
    Edes, Istvan
    Blake, Gavin
    Lotan, Chaim
    Maggioni, Aldo
    Savonitto, Stefano
    Lee, Cheol Whan
    Leiva Pons, Jose Luis
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (16): : 1527 - 1539
  • [38] Individualized antithrombotic therapy in high-risk cardiovascular patients
    Tegtmeyer, Roland
    Borst, Oliver
    Gawaz, Meinrad
    Rath, Dominik
    PERSONALIZED MEDICINE, 2018, 15 (03) : 223 - 236
  • [39] Lifestyles and psychosocial profiles in high-risk cardiovascular patients
    Michele, Koleck
    Morgann, Philippon
    Bernard, Gay
    Louis, Demeaux Jean
    PSYCHOLOGY & HEALTH, 2011, 26 : 150 - 151
  • [40] EVALUATING THE VALUE OF LOW-DOSE ASPIRIN IN PATIENTS AT HIGH-RISK OF CARDIOVASCULAR DISEASE
    Withers, K.
    Stainthorpe, A.
    Anstee, K.
    Detering, E.
    Yeo, S.
    VALUE IN HEALTH, 2020, 23 : S502 - S502
12345